Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec;9(1):687-690.
doi: 10.1080/22221751.2020.1741327.

Clinical observation and management of COVID-19 patients

Taisheng Li  1 , Hongzhou Lu  2 , Wenhong Zhang  3
Affiliations

Clinical observation and management of COVID-19 patients

Taisheng Li et al. Emerg Microbes Infect. 2020 Dec.

Abstract

Three leading infectious disease experts in China were invited to share their bedside observations in the management of COVID-19 patients. Professor Taisheng Li was sent to Wuhan to provide frontline medical care. He depicts the clinical course of SARS-CoV-2 infection. Furthermore, he observes the significant abnormality of coagulation function and proposes that the early intravenous immunoglobulin and low molecular weight heparin anticoagulation therapy are very important. Professor Hongzhou Lu, a leader in China to try various anti-viral drugs, expresses concern on the quality of the ongoing clinical trials as most trials are small in scale and repetitive in nature, and emphasizes the importance of the quick publication of clinical trial results. Regarding the traditional Chinese medicine, Professor Lu suggests to develop a creative evaluation system because of the complicated chemical compositions. Professor Wenhong Zhang is responsible for Shanghai's overall clinical management of the COVID-19 cases. He introduces the team approach to manage COVID-19 patients. For severe or critically ill patients, in addition to the respiratory supportive treatment, timely multiorgan evaluation and treatment is very crucial. The medical decisions and interventions are carefully tailored to the unique characteristics of each patient.

Keywords: Clinical management; SARS; SARS-CoV-2; antiviral drugs; coronavirus.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported by the author(s).

Figures

Figure 1.
Figure 1.
Ecchymosis in severe type of COVID-19 patients.
See this image and copyright information in PMC

References

    1. Chan JF, Kok KH, Zhu Z, et al. . Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microb Infect. 2020;9:221–236. doi: 10.1080/22221751.2020.1719902 - DOI - PMC - PubMed
    1. Chen L, Liu W, Zhang Q, et al. . RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak. Emerg Microb Infect. 2020;9:313–319. doi: 10.1080/22221751.2020.1725399 - DOI - PMC - PubMed
    1. Zhang W, Du RH, Li B, et al. . Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microb Infect. 2020;9:386–389. doi: 10.1080/22221751.2020.1729071 - DOI - PMC - PubMed
    1. Chen WL, Lan Y, Yuan XZ, et al. . Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity. Emerg Microb Infect. 2020;9:469–473. doi: 10.1080/22221751.2020.1732837 - DOI - PMC - PubMed
    1. Working Group of 2019 Novel Coronavirus, Peking Union Medical College Hospital . Diagnosis and clinical management of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking Union Medical College Hospital (V2.0). Emerg Microb Infect. 2020;9:582–585. - PMC - PubMed

MeSH terms

LinkOut - more resources